Investor Relations
Mar 23, 2018
OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes MORE >>
Mar 16, 2018
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology MORE >>
Mar 01, 2018
OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2018
OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018 MORE >>

SEC Filing Details

Document Details

Form
Filing Date
Apr 13, 2018
Document Date
Apr 12, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
OPKO Health, Inc.
Filer
FROST PHILLIP MD ET AL